- Katılım
- 27 Aralık 2008
- Mesajlar
- 432,578
- Reaksiyon puanı
- 0
- Puanları
- 0
Their study, published in the journal Cancer, adds to a growing body of evidence that the new drugs are far safer, preventing cancer with fewer side effects than tamoxifen.
Dr. Lauren Cassell of Lenox Hill Hospital in New York said the research is changing how doctors treat breast cancer patients after their tumors are surgically removed.
"If they have been on tamoxifen we are switching them to an aromatase inhibitor. If they are newly diagnosed we are using an aromatase inhibitor instead of tamoxifen," she said in a statement.
But tamoxifen remains the main option for younger women with breast cancer.
"Aromatase inhibitors are only for women who are post-menopausal," Cassell said.
Tamoxifen transformed breast cancer therapy when it was shown to reduce the risk of cancer coming back by close to 50 percent. It was also an easy-to-take pill.
But the drug raised the risk of death from strokes and endometrial cancer.
Kaynak: SağlıkHaber
Dr. Lauren Cassell of Lenox Hill Hospital in New York said the research is changing how doctors treat breast cancer patients after their tumors are surgically removed.
"If they have been on tamoxifen we are switching them to an aromatase inhibitor. If they are newly diagnosed we are using an aromatase inhibitor instead of tamoxifen," she said in a statement.
But tamoxifen remains the main option for younger women with breast cancer.
"Aromatase inhibitors are only for women who are post-menopausal," Cassell said.
Tamoxifen transformed breast cancer therapy when it was shown to reduce the risk of cancer coming back by close to 50 percent. It was also an easy-to-take pill.
But the drug raised the risk of death from strokes and endometrial cancer.
Kaynak: SağlıkHaber